A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers

ABSTRACT:

SUBMITTER: Cabanis M 

PROVIDER: S-EPMC10847620 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature